InflaRx
IFRX
42 hedge funds and large institutions have $56.8M invested in InflaRx in 2023 Q3 according to their latest regulatory filings, with 10 funds opening new positions, 14 increasing their positions, 8 reducing their positions, and 5 closing their positions.
133% more call options, than puts
Call options by funds: $343K | Put options by funds: $147K
100% more first-time investments, than exits
New positions opened: 10 | Existing positions closed: 5
75% more repeat investments, than reductions
Existing positions increased: 14 | Existing positions reduced: 8
14% more funds holding
Funds holding: 37 → 42 (+5)
0.75% more ownership
Funds ownership: 31.57% → 32.32% (+0.75%)
31% less capital invested
Capital invested by funds: $82.7M → $56.8M (-$26M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
IC
Ikarian Capital
Dallas,
Texas
|
+$2.62M |
| 2 |
6CM
683 Capital Management
New York
|
+$1.33M |
| 3 |
Point72 Asset Management
Stamford,
Connecticut
|
+$642K |
| 4 |
BFM
Boothbay Fund Management
New York
|
+$539K |
| 5 |
UOC
UBS O'Connor
Chicago,
Illinois
|
+$324K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
WP
Woodline Partners
San Francisco,
California
|
-$1.38M |
| 2 |
Millennium Management
New York
|
-$908K |
| 3 |
JGC
J. Goldman & Co
New York
|
-$777K |
| 4 |
EP
Eversept Partners
New York
|
-$676K |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$537K |
IFRX Hedge Fund Activity: Q3 2023 in Review
42 of the 6,310 institutional investors tracked by Wall St. Rank reported a position in InflaRx (IFRX) for Q3 2023, worth a combined $56.8M — down 31% from $82.7M a quarter earlier.
Buyers outnumbered sellers: 10 funds opened new IFRX positions and 5 closed out — a net gain of 5 holders — while 14 added to existing stakes and 8 trimmed.
The largest buyer was Ikarian Capital, opening a new position worth an estimated $2.62M. The largest seller was Woodline Partners, cutting an estimated $1.38M.
- 42 institutional investors held InflaRx (IFRX) as of Q3 2023, up from 37 in Q2 2023.
- Funds reported $56.8M of InflaRx stock for Q3 2023, down 31% quarter-over-quarter.
- 10 funds opened new InflaRx positions in Q3 2023 and 5 closed out, a net change of +5 holders.
- The largest InflaRx buyer in Q3 2023 was Ikarian Capital, an estimated $2.62M added.
- The largest InflaRx seller in Q3 2023 was Woodline Partners, an estimated $1.38M sold.
Based on aggregated 13F filings for Q3 2023.